Aug 3, 2026, 11:50 PM EDT · 1 month ago SDEV: Abbott Cooper PLLC Announces Investigation on Behalf of Stablecoin Development Corporation (Formerly Novabay Pharmaceuticals, Inc.) Stockholders
Jul 31, 2026, 8:30 AM EDT · 2 months ago Stablecoin Development Corporation Reports Second Quarter 2026 Financial Results
Jun 17, 2026, 11:22 PM EDT · 3 months ago SDEV: Abbott Cooper PLLC Announces Investigation on Behalf of Stablecoin Development Corporation (Formerly NovaBay Pharmaceuticals, Inc.) Stockholders
May 20, 2026, 8:30 AM EDT · 4 months ago Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Apr 6, 2026, 8:30 AM EDT · 5 months ago Stablecoin Development Corporation Begins Trading on NYSE American Under Ticker “SDEV”
Mar 23, 2026, 8:30 AM EDT · 6 months ago NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update
Oct 20, 2025, 7:07 PM EDT · 11 months ago NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards
Sep 18, 2025, 4:30 PM EDT · 1 year ago NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting
Aug 26, 2025, 4:05 PM EDT · 1 year ago NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share
Aug 19, 2025, 5:25 PM EDT · 1 year ago NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
Mar 7, 2025, 6:50 AM EST · 1 year ago NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders
Jan 23, 2025, 8:00 AM EST · 1 year ago NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal
Dec 19, 2024, 6:50 AM EST · 1 year ago NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
Dec 9, 2024, 6:50 AM EST · 1 year ago NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting
Nov 22, 2024, 4:05 PM EST · 1 year ago NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024
Nov 15, 2024, 8:00 AM EST · 1 year ago Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand
Nov 7, 2024, 4:05 PM EST · 1 year ago NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results
Nov 6, 2024, 4:05 PM EST · 1 year ago NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price
Oct 29, 2024, 8:00 AM EDT · 1 year ago NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC
Sep 20, 2024, 8:30 AM EDT · 2 years ago Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals
Sep 20, 2024, 8:00 AM EDT · 2 years ago NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets
Aug 13, 2024, 4:05 PM EDT · 2 years ago NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results
Aug 1, 2024, 6:50 AM EDT · 2 years ago NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024
Jul 30, 2024, 6:50 AM EDT · 2 years ago NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales
Jul 29, 2024, 4:05 PM EDT · 2 years ago NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option
Jul 26, 2024, 8:30 AM EDT · 2 years ago NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering
Jul 16, 2024, 6:50 AM EDT · 2 years ago NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day
Jul 11, 2024, 6:50 AM EDT · 2 years ago NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million
Jul 1, 2024, 6:50 AM EDT · 2 years ago NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities
Jun 28, 2024, 6:50 AM EDT · 2 years ago NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions
Jun 7, 2024, 6:50 AM EDT · 2 years ago NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American
May 29, 2024, 5:22 PM EDT · 2 years ago NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates
May 13, 2024, 8:30 AM EDT · 2 years ago NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms
May 9, 2024, 4:05 PM EDT · 2 years ago NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results
May 7, 2024, 8:00 AM EDT · 2 years ago NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon
May 3, 2024, 6:50 AM EDT · 2 years ago NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024
Apr 22, 2024, 6:57 AM EDT · 2 years ago NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales
Apr 19, 2024, 6:00 PM EDT · 2 years ago NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity
Apr 17, 2024, 6:59 AM EDT · 2 years ago NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
Mar 26, 2024, 4:05 PM EDT · 2 years ago NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
Mar 25, 2024, 6:38 PM EDT · 2 years ago NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024
Mar 14, 2024, 8:00 AM EDT · 2 years ago NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023
Jan 30, 2024, 9:00 AM EST · 2 years ago NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales
Jan 9, 2024, 9:15 AM EST · 2 years ago NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network SNOA
Dec 6, 2023, 6:50 AM EST · 2 years ago NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes
Nov 9, 2023, 4:05 PM EST · 2 years ago NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results
Nov 2, 2023, 6:50 AM EDT · 2 years ago NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023
Oct 11, 2023, 8:00 AM EDT · 2 years ago NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs
Oct 2, 2023, 6:50 AM EDT · 3 years ago NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference